Particle.news
Download on the App Store

Mayo Clinic Targets 'Stem-Like' T Cells With Diagnostic Tool to Predict Autoimmune Risk

The effort builds on discoveries that malfunctioning checkpoints allow youthful T cells to fuel giant cell arteritis in older adults.

Overview

  • Researchers analyzing tissue from over 100 patients with giant cell arteritis found a subset in their 60s and 70s whose immune profiles resembled those of much younger individuals.
  • Specialized stem-like T cells concentrated in diseased arterial tissue appear to regenerate immune responses as in youth but also promote autoimmune attacks.
  • Malfunctioning immune checkpoint proteins failed to restrain these youthful cells, helping to explain how they drive tissue inflammation.
  • The Mayo Clinic team is now developing tests to detect elevated levels of these stem-like T cells and assess autoimmune risk in older adults.
  • The findings challenge assumptions about blanket immune rejuvenation and prompt broader studies into prevalence, mechanisms and potential therapies.